| Product Code: ETC6191640 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Spasticity Treatment Market in Australia is driven by the need to manage muscle stiffness associated with conditions like cerebral palsy, multiple sclerosis, and stroke. Treatments range from pharmacological solutions to physical therapy and advanced neuromodulation devices. The aging population and rising incidence of neurological disorders underpin steady market growth.
The market for spasticity treatment in Australia is growing with increased prevalence of neurological disorders and post-stroke conditions. Innovations in pharmacological treatments, including botulinum toxin formulations, combined with physiotherapy and assistive technologies, are enhancing patient outcomes and quality of life.
The spasticity treatment market faces issues including delayed diagnosis and limited access to specialized neurorehabilitation services. High treatment costs, especially for advanced therapies like botulinum toxin injections or intrathecal baclofen pumps, reduce accessibility. In rural areas, physiotherapy services are scarce.
The spasticity treatment market in Australia offers investment potential through innovative pharmaceutical products, physical therapy technologies, and medical devices such as neuromodulation systems. Aging populations and increasing incidences of neurological disorders drive demand. Opportunities also exist in specialized clinics and home-care solutions, supported by government healthcare funding and insurance reimbursements.
Healthcare policies under Medicare and state health departments provide funding and reimbursement frameworks for spasticity treatments. The Therapeutic Goods Administration (TGA) regulates medical devices and pharmaceuticals used in treatment. Government initiatives for disability support also enhance access to therapies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Spasticity Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Spasticity Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Spasticity Treatment Market - Industry Life Cycle |
3.4 Australia Spasticity Treatment Market - Porter's Five Forces |
3.5 Australia Spasticity Treatment Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 Australia Spasticity Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Australia Spasticity Treatment Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Australia Spasticity Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Spasticity Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.10 Australia Spasticity Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.11 Australia Spasticity Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Australia Spasticity Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders leading to spasticity |
4.2.2 Technological advancements in spasticity treatment options |
4.2.3 Growing awareness and healthcare infrastructure in Australia |
4.3 Market Restraints |
4.3.1 High treatment costs associated with spasticity management |
4.3.2 Limited accessibility to specialized healthcare services in rural areas |
5 Australia Spasticity Treatment Market Trends |
6 Australia Spasticity Treatment Market, By Types |
6.1 Australia Spasticity Treatment Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 Australia Spasticity Treatment Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 Australia Spasticity Treatment Market Revenues & Volume, By Physical Therapy, 2021- 2031F |
6.1.4 Australia Spasticity Treatment Market Revenues & Volume, By Occupational Therapy, 2021- 2031F |
6.2 Australia Spasticity Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Australia Spasticity Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Australia Spasticity Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3 Australia Spasticity Treatment Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Australia Spasticity Treatment Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.3.3 Australia Spasticity Treatment Market Revenues & Volume, By Dantrolene Sodium, 2021- 2031F |
6.3.4 Australia Spasticity Treatment Market Revenues & Volume, By Gabapentin, 2021- 2031F |
6.3.5 Australia Spasticity Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Spasticity Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Spasticity Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Australia Spasticity Treatment Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.4.4 Australia Spasticity Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Spasticity Treatment Market, By Indication |
6.5.1 Overview and Analysis |
6.5.2 Australia Spasticity Treatment Market Revenues & Volume, By Multiple Sclerosis (MS), 2021- 2031F |
6.5.3 Australia Spasticity Treatment Market Revenues & Volume, By Cerebral Palsy (CP), 2021- 2031F |
6.5.4 Australia Spasticity Treatment Market Revenues & Volume, By Traumatic Brain Injury (TBI), 2021- 2031F |
6.5.5 Australia Spasticity Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Australia Spasticity Treatment Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Australia Spasticity Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Australia Spasticity Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Australia Spasticity Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7 Australia Spasticity Treatment Market, By End-Users |
6.7.1 Overview and Analysis |
6.7.2 Australia Spasticity Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Australia Spasticity Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.7.4 Australia Spasticity Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Australia Spasticity Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Spasticity Treatment Market Import-Export Trade Statistics |
7.1 Australia Spasticity Treatment Market Export to Major Countries |
7.2 Australia Spasticity Treatment Market Imports from Major Countries |
8 Australia Spasticity Treatment Market Key Performance Indicators |
8.1 Patient satisfaction with spasticity treatment options |
8.2 Number of healthcare facilities offering spasticity treatment services |
8.3 Research and development investment in new spasticity treatment technologies |
8.4 Percentage of healthcare professionals trained in spasticity management |
8.5 Utilization rate of non-pharmacological interventions for spasticity |
9 Australia Spasticity Treatment Market - Opportunity Assessment |
9.1 Australia Spasticity Treatment Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 Australia Spasticity Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Australia Spasticity Treatment Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Australia Spasticity Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Spasticity Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.6 Australia Spasticity Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.7 Australia Spasticity Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Australia Spasticity Treatment Market - Competitive Landscape |
10.1 Australia Spasticity Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Spasticity Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |